ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
1,2,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
2,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4,1,Migraine,Migraine headaches,Headaches,Nerv,N
5,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
6,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
7,2,Benign hydatidiform mole,Reproductive neoplasms female benign NEC,Reproductive neoplasms female benign,Neopl,N
8,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
12,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
13,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
14,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
15,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,2,Semen analysis abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
17,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
20,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
21,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
22,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
23,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
24,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
25,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
26,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
27,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
27,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
28,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
29,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
30,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
31,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
31,2,Rectal tenesmus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
32,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
33,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
35,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
35,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
36,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
36,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
37,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
37,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
38,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
38,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
38,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
40,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
42,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
42,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
44,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
45,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
46,1,Rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
47,1,Mechanical urticaria,Urticarias,Angioedema and urticaria,Skin,N
47,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
48,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
49,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
50,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
51,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
51,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
52,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
53,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
53,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
54,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
55,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
55,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
55,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
57,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
59,1,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
60,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
60,2,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
61,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
61,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
62,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
63,1,Aortic valve stenosis,Aortic valvular disorders,Cardiac valve disorders,Card,Y
63,2,Foetal disorder,Foetal complications NEC,Foetal complications,Preg,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
65,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
65,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
67,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,3,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
67,4,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,5,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
67,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
67,7,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,8,Blood immunoglobulin G increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
67,9,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
67,10,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,11,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
67,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
67,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,14,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
67,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
69,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
69,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
70,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
70,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
70,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
70,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
70,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
70,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
71,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
71,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
71,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
72,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
72,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
73,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
74,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
74,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
74,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
74,4,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
75,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
75,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
76,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
76,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
76,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
76,4,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
76,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
76,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
76,7,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
76,8,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
76,9,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
76,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
77,1,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
78,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
78,3,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
78,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,6,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
78,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
78,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
80,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
80,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
82,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
83,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
83,2,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
83,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
84,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
84,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
84,3,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
84,4,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
84,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
84,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
84,7,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
84,8,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
84,9,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,10,Headache,Headaches NEC,Headaches,Nerv,N
84,11,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
85,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
85,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,1,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
86,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
87,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
87,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
89,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
89,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
89,3,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
89,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
89,5,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
89,6,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
89,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
89,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,9,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
89,10,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
89,11,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
89,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
89,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
89,14,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
89,15,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
89,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
89,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
89,18,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
89,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
90,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
90,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
91,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,4,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
91,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
91,6,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
91,7,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
91,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,10,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
91,11,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,12,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,13,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,14,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
91,16,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,17,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
91,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
91,20,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
91,21,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
91,22,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
92,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,4,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
92,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
92,6,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
92,7,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
92,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
92,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,10,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
92,11,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,12,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,13,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
92,14,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
92,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
92,16,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
92,17,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
92,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
92,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
92,20,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
92,21,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
92,22,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
93,1,Headache,Headaches NEC,Headaches,Nerv,N
93,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
93,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
95,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
95,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
95,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
96,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
97,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
98,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
99,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
100,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
100,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
100,3,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
100,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
100,5,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
100,6,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
100,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,9,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
100,10,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
100,11,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
100,14,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
100,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
100,17,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
100,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
101,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
102,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
103,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
103,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
103,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
104,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
105,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
105,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
106,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
108,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
108,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
108,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
109,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
109,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
111,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
111,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
111,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
111,4,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
111,5,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
111,6,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
112,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
112,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
113,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
114,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
115,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
115,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
115,3,Cold-stimulus headache,Headaches NEC,Headaches,Nerv,N
115,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
115,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
115,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
116,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
117,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
117,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
117,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
117,4,Weight decrease neonatal,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
118,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
118,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
119,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
119,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
119,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
120,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
121,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
121,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
121,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
121,4,Migraine,Migraine headaches,Headaches,Nerv,N
121,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
121,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
122,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
122,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
123,2,Headache,Headaches NEC,Headaches,Nerv,N
123,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
125,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
126,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
126,2,Device placement issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
126,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
126,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
127,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
127,2,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
127,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
128,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
128,2,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
129,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
129,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
129,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
130,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
131,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
131,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
132,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
133,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
133,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
133,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
134,1,Headache,Headaches NEC,Headaches,Nerv,N
135,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
135,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
137,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
138,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
139,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
139,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
